The burden of breast cancer among women aged ≥70 years: Global trends in DALYs and mortality by socio-demographic index, 1990–2023.

S Siddique Ahmed (Nishtar Medical University, Multan, Pakistan) S Sarim Hassan Shahab (Nishtar Medical University, Multan, Punjab, Pakistan) M Muhammad Umar S Sanhia Maheshwari (Jinnah Sindh Medical University, Karachi, Pakistan) M Minahil Zahid (Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan) F FNU Sawaira (5Peshawar Girls Medical College, Peshawar, Peshawar, Pakistan) A Abdul Haseeb Shehzad (The Jewish Hospital, Cincinnati, OH) I Imran Naqvi (The Jewish Hospital, Cincinnati, OH) A Abubakar Nazir (The Jewish Hospital- Mercy Health, Cincinnati, Ohio, United States) O Owais Gul (United Health Services Hospitals, Johnson City, NY)

Abstract

e12700 Background: Breast cancer remains a major public health concern with high morbidity and mortality worldwide, particularly among women aged ≥70 years. Despite advances in diagnosis, treatment, and prevention, substantial disparities in DALYs and mortality persist across socio-demographic index (SDI) regions. Methods: Data from GBD 2023 were used to assess Disability Adjusted Life Years (DALYs) and mortality rates per 100,000 population in women aged ≥70 years. Analyses were stratified by SDI groups (low, low-middle, middle, high-middle). Joinpoint regression estimated trends, and AAPC with 95% CI was calculated; p < 0.05 indicated significance. Results: From 1990 to 2023, the consistently higher rates in DALYs were observed in the middle SDI group, with rates rising from 120.79 in 1990 to 299.32 in 2023 (AAPC: 2.83; 95% CI: 2.74 to 2.91; p < 0.000001). This was followed by the low-middle SDI group, which showed a continuous increase in DALYs from 117.09 in 1999 to 297.63 in 2023 (AAPC: 2.87; 95% CI: 2.66 to 3.09; p < 0.000001). The low SDI group demonstrated comparatively lower rates; however, DALYs still rose markedly from 114.47 in 1999 to 262.25 in 2023 (AAPC: 2.52; 95% CI: 2.32 to 2.72; p < 0.000001). The high-middle SDI group also experienced a modest but comparatively lower increase, with DALYs rising from 143.67 in 1990 to 230.74 in 2023 (AAPC: 1.46; 95% CI: 1.30 to 1.62; p < 0.000001). A similar pattern was noted in mortality trends. From 1980 to 2023, the middle SDI group exhibited the highest mortality rates, increasing from 5.02 in 1980 to 14.88 in 2023 (AAPC: 2.59; 95% CI: 2.52 to 2.66; p < 0.000001). The low-middle SDI group followed, with mortality rising from 4.82 in 1980 to 14.26 in 2023 (AAPC: 2.58; 95% CI: 2.28 to 2.87; p < 0.000001). The low SDI group recorded lower but steadily increasing rates, from 4.84 in 1980 to 11.73 in 2023 (AAPC: 2.08; 95% CI: 1.90 to 2.26; p < 0.000001). The high-middle SDI group showed the smallest relative rise, with mortality increasing from 6.46 in 1980 to 11.69 in 2023 (AAPC: 1.38; 95% CI: 1.23 to 1.53; p < 0.000001). Conclusions: Breast cancer in women aged ≥70 years remains a significant global health burden, with the highest impact in middle and low-middle SDI regions. Strengthening geriatric-focused screening, timely diagnosis, and equitable treatment strategies is critical to reduce disease burden in this population. Average annual percentage changes (AAPC) for mortality rates and disability adjusted life years (DALYs) rates for each region. Mortality Rates per 100,000 Disability Adjusted Life Years (DALYs) per 100,000 Region AAPC Region AAPC Low SDI 2.0817* Low SDI 2.5255* Low-middle SDI 2.5810* Low-middle SDI 2.8792* Middle SDI 2.5916* Middle SDI 2.8313* High-middle SDI 1.3828* High-middle SDI 1.4662* *Shows that the trend was statistically significant at alpha = 0.05.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

S

Siddique Ahmed

Nishtar Medical University, Multan, Pakistan

S

Sarim Hassan Shahab

Nishtar Medical University, Multan, Punjab, Pakistan

M

Muhammad Umar

S

Sanhia Maheshwari

Jinnah Sindh Medical University, Karachi, Pakistan

M

Minahil Zahid

Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan

F

FNU Sawaira

5Peshawar Girls Medical College, Peshawar, Peshawar, Pakistan

A

Abdul Haseeb Shehzad

The Jewish Hospital, Cincinnati, OH

I

Imran Naqvi

The Jewish Hospital, Cincinnati, OH

A

Abubakar Nazir

The Jewish Hospital- Mercy Health, Cincinnati, Ohio, United States

O

Owais Gul

United Health Services Hospitals, Johnson City, NY